$NVR
NVR INC Stock $nvr

$nvr Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000090616323000048 Filed on May 02, 2023

Income Statement

Concept	2023 Q1
Revenue	$2.178B
YoY Change	-8.41%
Cost Of Revenue	$1.608B
YoY Change	-2.63%
Gross Profit	$607.3M
YoY Change	-16.98%
Gross Profit Margin	27.88%
Selling, General & Admin	$166.3M
YoY Change	9.08%
% of Gross Profit	27.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.188M
YoY Change	-6.1%
% of Gross Profit	0.69%
Operating Expenses	$166.3M
YoY Change	9.08%
Operating Profit	$441.1M
YoY Change	-23.84%
Interest Expense	$7.258M
YoY Change	-44.87%
% of Operating Profit	1.65%
Other Income/Expense, Net
YoY Change
Pretax Income	$433.8M
YoY Change	-23.35%
Income Tax	$89.46M
% Of Pretax Income	20.62%
Net Earnings	$344.4M
YoY Change	-19.19%
Net Earnings / Revenue	15.81%
Basic Earnings Per Share	$106.30
Diluted Earnings Per Share	$99.89
COMMON SHARES
Basic Shares Outstanding	3.249M shares
Diluted Shares Outstanding	3.447M shares

Balance Sheet

Concept	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.801B
YoY Change	29.79%
Cash & Equivalents	$2.859B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$1.866B
Prepaid Expenses
Receivables	$23.31M
Other Receivables	$0.00
Total Short-Term Assets	$4.690B
YoY Change	7.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$153.2M
YoY Change	19.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.20M
YoY Change	44.68%
Other Assets	$57.83M
YoY Change	-16.46%
Total Long-Term Assets	$1.386B
YoY Change	2.59%
TOTAL ASSETS
Total Short-Term Assets	$4.690B
Total Long-Term Assets	$1.386B
Total Assets	$6.076B
YoY Change	6.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$422.1M
YoY Change	-7.56%
Accrued Expenses	$558.8M
YoY Change	-2.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.316B
YoY Change	-11.35%
LONG-TERM LIABILITIES
Long-Term Debt	$914.4M
YoY Change	-39.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$914.4M
YoY Change	-39.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.316B
Total Long-Term Liabilities	$914.4M
Total Liabilities	$2.231B
YoY Change	-25.66%
SHAREHOLDERS EQUITY
Retained Earnings	$12.12B
YoY Change	15.69%
Common Stock	$2.677B
YoY Change	10.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.95B
YoY Change	7.71%
Treasury Stock Shares
Shareholders Equity	$3.845B
YoY Change
Total Liabilities & Shareholders Equity	$6.076B
YoY Change	6.11%

Cashflow Statement

Concept	2023 Q1
OPERATING ACTIVITIES
Net Income	$344.4M
YoY Change	-19.19%
Depreciation, Depletion And Amortization	$4.188M
YoY Change	-6.1%
Cash From Operating Activities	$315.5M
YoY Change	2.0%
INVESTING ACTIVITIES
Capital Expenditures	$2.714M
YoY Change	-33.09%
Acquisitions
YoY Change
Other Investing Activities	-$201.0K
YoY Change	-23.28%
Cash From Investing Activities	-$2.915M
YoY Change	-32.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$28.53M
YoY Change	-96.01%
NET CHANGE
Cash From Operating Activities	$315.5M
Cash From Investing Activities	-$2.915M
Cash From Financing Activities	-$28.53M
Net Change In Cash	$284.1M
YoY Change	-169.3%
FREE CASH FLOW
Cash From Operating Activities	$315.5M
Capital Expenditures	$2.714M
Free Cash Flow	$312.8M
YoY Change	2.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000906163
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-12378
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NVR, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1394360
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	11700 Plaza America Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Reston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20190
CY2023Q1	dei	City Area Code CityAreaCode	703
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	956-4000
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	NVR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3246946	shares
CY2023Q1	us-gaap	Assets Assets	6075905000	usd
CY2022Q4	us-gaap	Assets Assets	5660973000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2230559000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2154124000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12117766000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20555330	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20555330	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	206000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	206000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2676641000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2600014000	usd
CY2023Q1	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	106697	shares
CY2022Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	106697	shares
CY2023Q1	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	16710000	usd
CY2022Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	16710000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	16710000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	16710000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11773414000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17313580	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17336397	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	10949267000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10866785000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3845346000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3506849000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6075905000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5660973000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	433810000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	565945000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89458000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139845000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	344352000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	426100000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	106.31
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	125.87
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	99.89
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	116.56
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3239000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3385000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3447000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3656000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	344352000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	426100000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4188000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4460000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	22277000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11668000	usd
CY2023Q1	nvr	Contract Land Deposit Impairment Recoveries ContractLandDepositImpairmentRecoveries	-3072000	usd
CY2022Q1	nvr	Contract Land Deposit Impairment Recoveries ContractLandDepositImpairmentRecoveries	-5924000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	37268000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	57978000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1237589000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1484771000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1238337000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1511850000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1000000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2000000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77267000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	246273000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	2515000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	8979000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-9801000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	13782000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50607000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	127083000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	21426000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	35715000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-18755000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	8157000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	315522000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	309326000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	565000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	472000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	180000	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2714000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4056000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	184000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	210000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2915000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4318000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	110048000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	748788000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	400000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	356000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	81916000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34241000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28532000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-714903000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	284075000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-409895000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2574518000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2636984000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2858593000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2227089000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	859000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	12521000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5423000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2536000	usd
CY2023Q1	nvr	Net Contract Land Deposit Impairment Recoveries NetContractLandDepositImpairmentRecoveries	3100000	usd
CY2022Q1	nvr	Net Contract Land Deposit Impairment Recoveries NetContractLandDepositImpairmentRecoveries	5900000	usd
CY2023Q1	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	53469000	usd
CY2022Q4	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	57060000	usd
CY2023Q1	nvr	Contract Land Deposits ContractLandDeposits	555136000	usd
CY2022Q4	nvr	Contract Land Deposits ContractLandDeposits	553140000	usd
CY2023Q1	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	53469000	usd
CY2022Q4	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	57060000	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	501667000	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	496080000	usd
CY2023Q1	nvr	Letters Of Credit Related To Lots LettersOfCreditRelatedToLots	7929000	usd
CY2022Q4	nvr	Letters Of Credit Related To Lots LettersOfCreditRelatedToLots	6896000	usd
CY2023Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	509596000	usd
CY2022Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	502976000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	26800000	usd
CY2023Q1	nvr	Number Of Joint Ventures NumberOfJointVentures	4	joint_venture
CY2023Q1	nvr	Expected Production Of Finished Lots From Joint Ventures ExpectedProductionOfFinishedLotsFromJointVentures	5300	lot
CY2023Q1	nvr	Joint Venture Lots Controlled By Company JointVentureLotsControlledByCompany	4900	lot
CY2023Q1	nvr	Joint Venture Lots Either Under Contract With Unrelated Parties Or Not Under Contract JointVentureLotsEitherUnderContractWithUnrelatedPartiesOrNotUnderContract	400	lot
CY2023Q1	nvr	Aggregate Additional Funding Commitments AggregateAdditionalFundingCommitments	12400000	usd
CY2023Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	28814000	usd
CY2023Q1	nvr	Number Of Finished Lots Expected To Be Developed From Raw Parcels Of Land NumberOfFinishedLotsExpectedToBeDevelopedFromRawParcelsOfLand	1900	lot
CY2023Q1	nvr	Aggregate Additional Funding Commitments Related To Raw Land Property Development AggregateAdditionalFundingCommitmentsRelatedToRawLandPropertyDevelopment	1900000	usd
CY2023Q1	nvr	Expected Development Credit ExpectedDevelopmentCredit	900000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	570000	usd
CY2021Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	593000	usd
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	7004000	usd
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	13254000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7258000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	13166000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	111000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	41000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	205000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	640000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3239263	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3385259	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	208211	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	270258	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3447474	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3655517	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	184114	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21032	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3506849000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	344352000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	110048000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22277000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	81916000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3845346000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3002378000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	426100000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	748788000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11668000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	34241000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2725599000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	21174	shares
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	146054	shares
CY2023Q1	nvr	Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther	43941	shares
CY2022Q1	nvr	Stock Issued During Period Shares Treasury Stock Reissued Upon Exercise Of Stock Option And Other StockIssuedDuringPeriodSharesTreasuryStockReissuedUponExerciseOfStockOptionAndOther	13323	shares
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	144006000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	134859000	usd
CY2023Q1	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	21270000	usd
CY2022Q1	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	17967000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20845000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	17485000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	144431000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	135341000	usd
CY2023Q1	us-gaap	Revenues Revenues	2178277000	usd
CY2022Q1	us-gaap	Revenues Revenues	2378409000	usd
CY2023Q1	nvr	Corporate Interest Income CorporateInterestIncome	29939000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	433810000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	565945000	usd
CY2023Q1	us-gaap	Assets Assets	6075905000	usd
CY2022Q4	us-gaap	Assets Assets	5660973000	usd
CY2023Q1	nvr	Fair Value Measurement Assumed Gain Loss From Loan Sale FairValueMeasurementAssumedGainLossFromLoanSale	4757000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	20
CY2023Q1	nvr	Fair Value Measurements Interest Rate Movement Effect FairValueMeasurementsInterestRateMovementEffect	12561000	usd
CY2023Q1	nvr	Fair Value Measurements Changes In Servicing Rights Value FairValueMeasurementsChangesInServicingRightsValue	31610000	usd
CY2023Q1	nvr	Fair Value Measurements Security Price Change Gain Loss Included In Earnings FairValueMeasurementsSecurityPriceChangeGainLossIncludedInEarnings	-14175000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	34753000	usd
CY2022	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-7435000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13492000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	14851000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13745000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	15002000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P17Y4M24D
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	9140000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	8101000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	502000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	464000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	105000	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	104000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7492000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6332000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	17239000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	15001000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	7316000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	7169000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	105000	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	104000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	400000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	356000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	13247000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5813000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	249000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	272000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P10Y7M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P10Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.036
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.029
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.029
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.247
CY2023Q1	nvr	Adjustment To Income Tax Expense Income Tax Effect From Share Based Compensation Net AdjustmentToIncomeTaxExpenseIncomeTaxEffectFromShareBasedCompensationNet	23245000	usd
CY2022Q1	nvr	Adjustment To Income Tax Expense Income Tax Effect From Share Based Compensation Net AdjustmentToIncomeTaxExpenseIncomeTaxEffectFromShareBasedCompensationNet	8446000	usd

Files In Submission

Name	View Source	Status
nvr-20230331_cal.xml	Edgar Link	unprocessable
nvr-20230331_lab.xml	Edgar Link	unprocessable
0000906163-23-000048-index-headers.html	Edgar Link	pending
0000906163-23-000048-index.html	Edgar Link	pending
0000906163-23-000048.txt	Edgar Link	pending
0000906163-23-000048-xbrl.zip	Edgar Link	pending
exhibit311q12023.htm	Edgar Link	pending
exhibit312q12023.htm	Edgar Link	pending
exhibit32q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvr-20230331.htm	Edgar Link	pending
nvr-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
nvr-20230331_def.xml	Edgar Link	unprocessable
nvr-20230331_htm.xml	Edgar Link	completed
nvr-20230331_pre.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVR
NVR INC Stock $nvr

2023 Q1 Form 10-Q Financial Statement

#000090616323000048 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVR NVR INC Stock $nvr

2023 Q1 Form 10-Q Financial Statement

#000090616323000048 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVR
NVR INC Stock $nvr